A national vaccination program to prevent swine flu will begin in three weeks, now that the Food and Drug Administration has approved four vaccines against the disease. Preliminary data indicates that one dose should be enough to provide immunity in an adult—not two, as was initially believed—easing fears that there wouldn’t be enough vaccine to cover the entire at-risk population.
Still, supplies of the vaccine will initially be tight. The U.S. has ordered 195 million doses, but the first production runs are expected to turn out about 45 million doses. Those most at risk from the disease, including children and pregnant women, will get first crack at the vaccine.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
UK-India trade deal: how the social security arrangements will workThe Explainer A National Insurance exemption in the UK-India trade deal is causing concern but should British workers worry?
-
Man arrested after 'suspicious' fires at properties linked to Keir StarmerSpeed Read Prime minister thanks emergency services after fire at his former family home in north London
-
Elon Musk's SpaceX has created a new city in Texasunder the radar Starbase is home to SpaceX's rocket launch site
